Detalhe da pesquisa
1.
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.
Trials
; 22(1): 651, 2021 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563240